Eli Lilly misses on earnings but raises full-year guidance

The company reported adjusted earnings of $1.62, which missed analyst expectations of $1.73 for the quarter.

from Health and Science https://ift.tt/EtfSTim
https://ift.tt/fuFmXTC
https://ift.tt/c3Q2JXS